Association between Certain NSCLC Driver Mutations and Predictive Markers for Chemotherapy or PD-(L)1 Inhibition

This study aimed to analyze the association between driver mutations and predictive markers for some anti-tumor agents in non-small cell lung cancer (NSCLC). A cohort of 785 Chinese patients with NSCLC who underwent resection from March 2016 to November 2017 in the First Affiliated Hospital of Guangzhou Medical University was investigated...More